nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—Oxcarbazepine—epilepsy syndrome	0.282	1	CrCtD
Doxepin—CHRM3—epilepsy syndrome	0.0371	0.189	CbGaD
Doxepin—CHRM1—epilepsy syndrome	0.0346	0.176	CbGaD
Doxepin—CHRM2—epilepsy syndrome	0.0283	0.144	CbGaD
Doxepin—ADRA2A—epilepsy syndrome	0.0241	0.123	CbGaD
Doxepin—SLC6A4—epilepsy syndrome	0.0184	0.0938	CbGaD
Doxepin—CYP2C19—epilepsy syndrome	0.0174	0.0889	CbGaD
Doxepin—HTR2A—epilepsy syndrome	0.0141	0.0721	CbGaD
Doxepin—CYP2D6—epilepsy syndrome	0.0129	0.0659	CbGaD
Doxepin—Indecainide—Oxcarbazepine—epilepsy syndrome	0.0129	0.0606	CrCrCtD
Doxepin—Phenindione—Fosphenytoin—epilepsy syndrome	0.0127	0.0597	CrCrCtD
Doxepin—ABCB1—epilepsy syndrome	0.00923	0.0471	CbGaD
Doxepin—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.00898	0.0422	CrCrCtD
Doxepin—Phenindione—Phenytoin—epilepsy syndrome	0.00871	0.0409	CrCrCtD
Doxepin—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.00827	0.0389	CrCrCtD
Doxepin—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.00827	0.0389	CrCrCtD
Doxepin—Phenindione—Carbamazepine—epilepsy syndrome	0.00803	0.0378	CrCrCtD
Doxepin—Desipramine—Carbamazepine—epilepsy syndrome	0.0076	0.0357	CrCrCtD
Doxepin—Phenindione—Oxcarbazepine—epilepsy syndrome	0.0074	0.0348	CrCrCtD
Doxepin—Oxcarbazepine—Clobazam—epilepsy syndrome	0.00731	0.0343	CrCrCtD
Doxepin—Phenindione—Clobazam—epilepsy syndrome	0.0071	0.0334	CrCrCtD
Doxepin—Desipramine—Oxcarbazepine—epilepsy syndrome	0.00701	0.0329	CrCrCtD
Doxepin—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00682	0.0321	CrCrCtD
Doxepin—Oxcarbazepine—Diazepam—epilepsy syndrome	0.00679	0.0319	CrCrCtD
Doxepin—Trimipramine—Carbamazepine—epilepsy syndrome	0.00672	0.0316	CrCrCtD
Doxepin—Dimetacrine—Carbamazepine—epilepsy syndrome	0.00643	0.0302	CrCrCtD
Doxepin—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.00619	0.0291	CrCrCtD
Doxepin—Imipramine—Carbamazepine—epilepsy syndrome	0.00616	0.029	CrCrCtD
Doxepin—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.00592	0.0278	CrCrCtD
Doxepin—Clomipramine—Clobazam—epilepsy syndrome	0.0058	0.0273	CrCrCtD
Doxepin—Promethazine—Carbamazepine—epilepsy syndrome	0.0057	0.0268	CrCrCtD
Doxepin—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00568	0.0378	CbGbCtD
Doxepin—Imipramine—Oxcarbazepine—epilepsy syndrome	0.00568	0.0267	CrCrCtD
Doxepin—Chlorprothixene—Midazolam—epilepsy syndrome	0.00568	0.0267	CrCrCtD
Doxepin—Alimemazine—Carbamazepine—epilepsy syndrome	0.0056	0.0263	CrCrCtD
Doxepin—Clomipramine—Diazepam—epilepsy syndrome	0.0054	0.0254	CrCrCtD
Doxepin—CYP2C19—Trimethadione—epilepsy syndrome	0.00528	0.0351	CbGbCtD
Doxepin—CYP2C19—Felbamate—epilepsy syndrome	0.00528	0.0351	CbGbCtD
Doxepin—Promethazine—Oxcarbazepine—epilepsy syndrome	0.00525	0.0247	CrCrCtD
Doxepin—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.00516	0.0242	CrCrCtD
Doxepin—Chlorprothixene—Diazepam—epilepsy syndrome	0.00506	0.0238	CrCrCtD
Doxepin—ABCB1—Levetiracetam—epilepsy syndrome	0.00501	0.0333	CbGbCtD
Doxepin—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00497	0.033	CbGbCtD
Doxepin—Diphenhydramine—Phenytoin—epilepsy syndrome	0.00486	0.0228	CrCrCtD
Doxepin—Promazine—Carbamazepine—epilepsy syndrome	0.00482	0.0227	CrCrCtD
Doxepin—Promazine—Oxcarbazepine—epilepsy syndrome	0.00444	0.0209	CrCrCtD
Doxepin—CYP2C9—Trimethadione—epilepsy syndrome	0.00439	0.0292	CbGbCtD
Doxepin—CYP2C19—Clobazam—epilepsy syndrome	0.00431	0.0286	CbGbCtD
Doxepin—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00413	0.0274	CbGbCtD
Doxepin—CYP2C19—Carbamazepine—epilepsy syndrome	0.00357	0.0237	CbGbCtD
Doxepin—ABCB1—Clobazam—epilepsy syndrome	0.00348	0.0231	CbGbCtD
Doxepin—ABCB1—Lamotrigine—epilepsy syndrome	0.00335	0.0222	CbGbCtD
Doxepin—CYP2C19—Primidone—epilepsy syndrome	0.00333	0.0221	CbGbCtD
Doxepin—CYP1A2—Carbamazepine—epilepsy syndrome	0.00329	0.0219	CbGbCtD
Doxepin—CYP2C19—Phenytoin—epilepsy syndrome	0.0032	0.0213	CbGbCtD
Doxepin—CYP1A2—Primidone—epilepsy syndrome	0.00307	0.0204	CbGbCtD
Doxepin—CYP2C19—Propofol—epilepsy syndrome	0.00299	0.0198	CbGbCtD
Doxepin—CYP2C9—Carbamazepine—epilepsy syndrome	0.00297	0.0197	CbGbCtD
Doxepin—ABCB1—Carbamazepine—epilepsy syndrome	0.00288	0.0191	CbGbCtD
Doxepin—CYP2C19—Phenobarbital—epilepsy syndrome	0.00285	0.019	CbGbCtD
Doxepin—CYP2C9—Primidone—epilepsy syndrome	0.00277	0.0184	CbGbCtD
Doxepin—CYP1A2—Propofol—epilepsy syndrome	0.00276	0.0183	CbGbCtD
Doxepin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00275	0.0183	CbGbCtD
Doxepin—CYP2C19—Diazepam—epilepsy syndrome	0.00271	0.018	CbGbCtD
Doxepin—CYP2C9—Phenytoin—epilepsy syndrome	0.00266	0.0177	CbGbCtD
Doxepin—CYP2C19—Zonisamide—epilepsy syndrome	0.00264	0.0175	CbGbCtD
Doxepin—CYP1A2—Phenobarbital—epilepsy syndrome	0.00263	0.0175	CbGbCtD
Doxepin—ABCB1—Phenytoin—epilepsy syndrome	0.00258	0.0172	CbGbCtD
Doxepin—CYP3A4—Felbamate—epilepsy syndrome	0.00255	0.017	CbGbCtD
Doxepin—CYP3A4—Trimethadione—epilepsy syndrome	0.00255	0.017	CbGbCtD
Doxepin—CYP1A2—Diazepam—epilepsy syndrome	0.0025	0.0166	CbGbCtD
Doxepin—CYP2C9—Propofol—epilepsy syndrome	0.00248	0.0165	CbGbCtD
Doxepin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0024	0.016	CbGbCtD
Doxepin—CYP2C9—Phenobarbital—epilepsy syndrome	0.00237	0.0158	CbGbCtD
Doxepin—ABCB1—Phenobarbital—epilepsy syndrome	0.0023	0.0153	CbGbCtD
Doxepin—ABCB1—Midazolam—epilepsy syndrome	0.00227	0.0151	CbGbCtD
Doxepin—CYP2D6—Propofol—epilepsy syndrome	0.00227	0.0151	CbGbCtD
Doxepin—CYP2C9—Diazepam—epilepsy syndrome	0.00225	0.0149	CbGbCtD
Doxepin—ABCB1—Diazepam—epilepsy syndrome	0.00218	0.0145	CbGbCtD
Doxepin—CYP3A4—Clonazepam—epilepsy syndrome	0.00217	0.0144	CbGbCtD
Doxepin—CYP2C19—Valproic Acid—epilepsy syndrome	0.00213	0.0142	CbGbCtD
Doxepin—CYP3A4—Clobazam—epilepsy syndrome	0.00208	0.0138	CbGbCtD
Doxepin—CYP1A2—Valproic Acid—epilepsy syndrome	0.00197	0.0131	CbGbCtD
Doxepin—CYP2C19—Topiramate—epilepsy syndrome	0.00192	0.0128	CbGbCtD
Doxepin—CYP2C9—Valproic Acid—epilepsy syndrome	0.00177	0.0118	CbGbCtD
Doxepin—CYP3A4—Rufinamide—epilepsy syndrome	0.00177	0.0118	CbGbCtD
Doxepin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00173	0.0115	CbGbCtD
Doxepin—CYP3A4—Primidone—epilepsy syndrome	0.00161	0.0107	CbGbCtD
Doxepin—CYP3A4—Phenytoin—epilepsy syndrome	0.00155	0.0103	CbGbCtD
Doxepin—CYP3A4—Propofol—epilepsy syndrome	0.00144	0.00959	CbGbCtD
Doxepin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00138	0.00916	CbGbCtD
Doxepin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00138	0.00916	CbGbCtD
Doxepin—CYP3A4—Midazolam—epilepsy syndrome	0.00136	0.00904	CbGbCtD
Doxepin—CYP3A4—Diazepam—epilepsy syndrome	0.00131	0.00869	CbGbCtD
Doxepin—CYP3A4—Zonisamide—epilepsy syndrome	0.00128	0.00848	CbGbCtD
Doxepin—HTR2A—phrenic nerve—epilepsy syndrome	0.00126	0.0538	CbGeAlD
Doxepin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00103	0.00685	CbGbCtD
Doxepin—SLC6A2—locus ceruleus—epilepsy syndrome	0.000938	0.04	CbGeAlD
Doxepin—CYP3A4—Topiramate—epilepsy syndrome	0.00093	0.00618	CbGbCtD
Doxepin—HTR6—ganglion—epilepsy syndrome	0.000574	0.0245	CbGeAlD
Doxepin—HTR2A—locus ceruleus—epilepsy syndrome	0.000564	0.024	CbGeAlD
Doxepin—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000533	0.0227	CbGeAlD
Doxepin—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000498	0.0212	CbGeAlD
Doxepin—HTR2A—cerebellar cortex—epilepsy syndrome	0.000459	0.0196	CbGeAlD
Doxepin—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000448	0.0191	CbGeAlD
Doxepin—HTR2A—vagus nerve—epilepsy syndrome	0.000431	0.0184	CbGeAlD
Doxepin—DRD2—telencephalic ventricle—epilepsy syndrome	0.000405	0.0173	CbGeAlD
Doxepin—HTR2C—ganglion—epilepsy syndrome	0.000332	0.0141	CbGeAlD
Doxepin—HTR2A—pons—epilepsy syndrome	0.000325	0.0138	CbGeAlD
Doxepin—SLC6A4—ganglion—epilepsy syndrome	0.000314	0.0134	CbGeAlD
Doxepin—HTR2A—autonomic nervous system—epilepsy syndrome	0.000299	0.0128	CbGeAlD
Doxepin—HTR1A—ganglion—epilepsy syndrome	0.000279	0.0119	CbGeAlD
Doxepin—SLC6A2—ganglion—epilepsy syndrome	0.000277	0.0118	CbGeAlD
Doxepin—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000267	0.0114	CbGeAlD
Doxepin—DRD2—ganglion—epilepsy syndrome	0.000252	0.0107	CbGeAlD
Doxepin—HTR6—forebrain—epilepsy syndrome	0.000241	0.0103	CbGeAlD
Doxepin—SLC6A4—hindbrain—epilepsy syndrome	0.000238	0.0102	CbGeAlD
Doxepin—HTR6—telencephalon—epilepsy syndrome	0.000221	0.00943	CbGeAlD
Doxepin—HTR1A—hindbrain—epilepsy syndrome	0.000212	0.00902	CbGeAlD
Doxepin—ADRA1A—hindbrain—epilepsy syndrome	0.000195	0.00832	CbGeAlD
Doxepin—DRD2—hindbrain—epilepsy syndrome	0.000191	0.00815	CbGeAlD
Doxepin—ADRA1D—forebrain—epilepsy syndrome	0.000188	0.00801	CbGeAlD
Doxepin—ADRA1D—telencephalon—epilepsy syndrome	0.000173	0.00737	CbGeAlD
Doxepin—HTR2A—ganglion—epilepsy syndrome	0.000166	0.00709	CbGeAlD
Doxepin—CHRM4—head—epilepsy syndrome	0.000154	0.00657	CbGeAlD
Doxepin—Olopatadine—S100B—epilepsy syndrome	0.000153	0.0826	CrCbGaD
Doxepin—CHRM4—nervous system—epilepsy syndrome	0.000146	0.00622	CbGeAlD
Doxepin—CHRM2—forebrain—epilepsy syndrome	0.000144	0.00615	CbGeAlD
Doxepin—HTR2C—brainstem—epilepsy syndrome	0.000144	0.00614	CbGeAlD
Doxepin—CHRM4—central nervous system—epilepsy syndrome	0.000141	0.00599	CbGeAlD
Doxepin—HTR2C—forebrain—epilepsy syndrome	0.000139	0.00593	CbGeAlD
Doxepin—HTR6—head—epilepsy syndrome	0.000138	0.00587	CbGeAlD
Doxepin—SLC6A4—brainstem—epilepsy syndrome	0.000137	0.00582	CbGeAlD
Doxepin—CHRM2—telencephalon—epilepsy syndrome	0.000133	0.00566	CbGeAlD
Doxepin—SLC6A4—forebrain—epilepsy syndrome	0.000132	0.00562	CbGeAlD
Doxepin—CHRM1—forebrain—epilepsy syndrome	0.000131	0.0056	CbGeAlD
Doxepin—HTR6—nervous system—epilepsy syndrome	0.000131	0.00557	CbGeAlD
Doxepin—HTR2B—forebrain—epilepsy syndrome	0.000131	0.00557	CbGeAlD
Doxepin—HTR2C—telencephalon—epilepsy syndrome	0.000128	0.00545	CbGeAlD
Doxepin—HTR2A—hindbrain—epilepsy syndrome	0.000126	0.00538	CbGeAlD
Doxepin—HRH2—head—epilepsy syndrome	0.000126	0.00537	CbGeAlD
Doxepin—HTR6—central nervous system—epilepsy syndrome	0.000126	0.00536	CbGeAlD
Doxepin—HTR1A—brainstem—epilepsy syndrome	0.000121	0.00517	CbGeAlD
Doxepin—SLC6A4—telencephalon—epilepsy syndrome	0.000121	0.00517	CbGeAlD
Doxepin—CHRM1—telencephalon—epilepsy syndrome	0.000121	0.00515	CbGeAlD
Doxepin—CHRM5—head—epilepsy syndrome	0.00012	0.00513	CbGeAlD
Doxepin—SLC6A2—brainstem—epilepsy syndrome	0.00012	0.00513	CbGeAlD
Doxepin—HTR2B—telencephalon—epilepsy syndrome	0.00012	0.00512	CbGeAlD
Doxepin—HRH2—nervous system—epilepsy syndrome	0.000119	0.00509	CbGeAlD
Doxepin—CHRM3—forebrain—epilepsy syndrome	0.000118	0.00501	CbGeAlD
Doxepin—HTR1A—forebrain—epilepsy syndrome	0.000117	0.00499	CbGeAlD
Doxepin—SLC6A2—forebrain—epilepsy syndrome	0.000116	0.00495	CbGeAlD
Doxepin—HRH2—central nervous system—epilepsy syndrome	0.000115	0.0049	CbGeAlD
Doxepin—CYP2D6—hindbrain—epilepsy syndrome	0.000115	0.0049	CbGeAlD
Doxepin—CHRM5—nervous system—epilepsy syndrome	0.000114	0.00486	CbGeAlD
Doxepin—ADRA1A—brainstem—epilepsy syndrome	0.000112	0.00477	CbGeAlD
Doxepin—CHRM4—brain—epilepsy syndrome	0.000112	0.00476	CbGeAlD
Doxepin—ADRA1B—head—epilepsy syndrome	0.00011	0.00469	CbGeAlD
Doxepin—CHRM5—central nervous system—epilepsy syndrome	0.00011	0.00468	CbGeAlD
Doxepin—DRD2—brainstem—epilepsy syndrome	0.00011	0.00467	CbGeAlD
Doxepin—CHRM3—telencephalon—epilepsy syndrome	0.000108	0.00461	CbGeAlD
Doxepin—ADRA1A—forebrain—epilepsy syndrome	0.000108	0.0046	CbGeAlD
Doxepin—HTR1A—telencephalon—epilepsy syndrome	0.000108	0.00459	CbGeAlD
Doxepin—ADRA1D—head—epilepsy syndrome	0.000108	0.00459	CbGeAlD
Doxepin—SLC6A2—telencephalon—epilepsy syndrome	0.000107	0.00455	CbGeAlD
Doxepin—DRD2—forebrain—epilepsy syndrome	0.000106	0.00451	CbGeAlD
Doxepin—ADRA1B—nervous system—epilepsy syndrome	0.000104	0.00445	CbGeAlD
Doxepin—KCNH2—forebrain—epilepsy syndrome	0.000104	0.00444	CbGeAlD
Doxepin—ADRA1D—nervous system—epilepsy syndrome	0.000102	0.00435	CbGeAlD
Doxepin—HTR2C—medulla oblongata—epilepsy syndrome	0.000101	0.00428	CbGeAlD
Doxepin—ADRA1B—central nervous system—epilepsy syndrome	0.0001	0.00428	CbGeAlD
Doxepin—HTR6—brain—epilepsy syndrome	9.99e-05	0.00426	CbGeAlD
Doxepin—ORM1—spinal cord—epilepsy syndrome	9.97e-05	0.00425	CbGeAlD
Doxepin—ADRA1A—telencephalon—epilepsy syndrome	9.93e-05	0.00423	CbGeAlD
Doxepin—ADRA1D—central nervous system—epilepsy syndrome	9.82e-05	0.00419	CbGeAlD
Doxepin—DRD2—telencephalon—epilepsy syndrome	9.73e-05	0.00415	CbGeAlD
Doxepin—KCNH2—telencephalon—epilepsy syndrome	9.59e-05	0.00409	CbGeAlD
Doxepin—ADRA2C—telencephalon—epilepsy syndrome	9.46e-05	0.00403	CbGeAlD
Doxepin—HTR2C—midbrain—epilepsy syndrome	9.19e-05	0.00392	CbGeAlD
Doxepin—HRH2—brain—epilepsy syndrome	9.13e-05	0.00389	CbGeAlD
Doxepin—HTR2C—spinal cord—epilepsy syndrome	8.96e-05	0.00382	CbGeAlD
Doxepin—CHRM5—brain—epilepsy syndrome	8.72e-05	0.00372	CbGeAlD
Doxepin—SLC6A4—midbrain—epilepsy syndrome	8.71e-05	0.00371	CbGeAlD
Doxepin—SLC6A4—spinal cord—epilepsy syndrome	8.5e-05	0.00362	CbGeAlD
Doxepin—ORM1—nervous system—epilepsy syndrome	8.4e-05	0.00358	CbGeAlD
Doxepin—SLC6A2—medulla oblongata—epilepsy syndrome	8.39e-05	0.00358	CbGeAlD
Doxepin—HRH1—forebrain—epilepsy syndrome	8.36e-05	0.00356	CbGeAlD
Doxepin—CHRM2—head—epilepsy syndrome	8.26e-05	0.00352	CbGeAlD
Doxepin—ADRA2A—forebrain—epilepsy syndrome	8.21e-05	0.0035	CbGeAlD
Doxepin—ORM1—central nervous system—epilepsy syndrome	8.09e-05	0.00345	CbGeAlD
Doxepin—ADRA1B—brain—epilepsy syndrome	7.97e-05	0.0034	CbGeAlD
Doxepin—HTR2C—head—epilepsy syndrome	7.97e-05	0.00339	CbGeAlD
Doxepin—CHRM2—nervous system—epilepsy syndrome	7.84e-05	0.00334	CbGeAlD
Doxepin—ADRA1D—brain—epilepsy syndrome	7.8e-05	0.00332	CbGeAlD
Doxepin—HTR1A—midbrain—epilepsy syndrome	7.73e-05	0.0033	CbGeAlD
Doxepin—HRH1—telencephalon—epilepsy syndrome	7.68e-05	0.00327	CbGeAlD
Doxepin—HTR2C—nervous system—epilepsy syndrome	7.55e-05	0.00322	CbGeAlD
Doxepin—SLC6A4—head—epilepsy syndrome	7.55e-05	0.00322	CbGeAlD
Doxepin—ADRA2A—telencephalon—epilepsy syndrome	7.55e-05	0.00322	CbGeAlD
Doxepin—HTR1A—spinal cord—epilepsy syndrome	7.54e-05	0.00322	CbGeAlD
Doxepin—CHRM2—central nervous system—epilepsy syndrome	7.54e-05	0.00322	CbGeAlD
Doxepin—KCNH2—medulla oblongata—epilepsy syndrome	7.53e-05	0.00321	CbGeAlD
Doxepin—CHRM1—head—epilepsy syndrome	7.52e-05	0.00321	CbGeAlD
Doxepin—HTR2B—head—epilepsy syndrome	7.48e-05	0.00319	CbGeAlD
Doxepin—ADRA2C—medulla oblongata—epilepsy syndrome	7.43e-05	0.00317	CbGeAlD
Doxepin—HTR2C—central nervous system—epilepsy syndrome	7.27e-05	0.0031	CbGeAlD
Doxepin—HTR2A—brainstem—epilepsy syndrome	7.23e-05	0.00308	CbGeAlD
Doxepin—SLC6A4—nervous system—epilepsy syndrome	7.16e-05	0.00305	CbGeAlD
Doxepin—CHRM1—nervous system—epilepsy syndrome	7.13e-05	0.00304	CbGeAlD
Doxepin—HTR2B—nervous system—epilepsy syndrome	7.09e-05	0.00302	CbGeAlD
Doxepin—DRD2—midbrain—epilepsy syndrome	6.99e-05	0.00298	CbGeAlD
Doxepin—HTR2A—forebrain—epilepsy syndrome	6.98e-05	0.00297	CbGeAlD
Doxepin—Imipramine—KCND2—epilepsy syndrome	6.98e-05	0.0376	CrCbGaD
Doxepin—Amitriptyline—KCND2—epilepsy syndrome	6.93e-05	0.0373	CrCbGaD
Doxepin—SLC6A4—central nervous system—epilepsy syndrome	6.89e-05	0.00294	CbGeAlD
Doxepin—KCNH2—midbrain—epilepsy syndrome	6.88e-05	0.00293	CbGeAlD
Doxepin—CHRM1—central nervous system—epilepsy syndrome	6.87e-05	0.00293	CbGeAlD
Doxepin—HTR2B—central nervous system—epilepsy syndrome	6.83e-05	0.00291	CbGeAlD
Doxepin—ADRA2C—midbrain—epilepsy syndrome	6.79e-05	0.00289	CbGeAlD
Doxepin—CHRM3—head—epilepsy syndrome	6.73e-05	0.00287	CbGeAlD
Doxepin—KCNH2—spinal cord—epilepsy syndrome	6.72e-05	0.00286	CbGeAlD
Doxepin—HTR1A—head—epilepsy syndrome	6.7e-05	0.00286	CbGeAlD
Doxepin—SLC6A2—head—epilepsy syndrome	6.65e-05	0.00283	CbGeAlD
Doxepin—ADRA2C—spinal cord—epilepsy syndrome	6.63e-05	0.00282	CbGeAlD
Doxepin—CYP2D6—brainstem—epilepsy syndrome	6.59e-05	0.00281	CbGeAlD
Doxepin—Amitriptyline—KCNQ3—epilepsy syndrome	6.45e-05	0.0347	CrCbGaD
Doxepin—Amitriptyline—KCNQ2—epilepsy syndrome	6.45e-05	0.0347	CrCbGaD
Doxepin—HTR2A—telencephalon—epilepsy syndrome	6.42e-05	0.00273	CbGeAlD
Doxepin—CHRM3—nervous system—epilepsy syndrome	6.38e-05	0.00272	CbGeAlD
Doxepin—CYP2D6—forebrain—epilepsy syndrome	6.36e-05	0.00271	CbGeAlD
Doxepin—HTR1A—nervous system—epilepsy syndrome	6.36e-05	0.00271	CbGeAlD
Doxepin—Doxylamine—CHRM1—epilepsy syndrome	6.32e-05	0.034	CrCbGaD
Doxepin—SLC6A2—nervous system—epilepsy syndrome	6.3e-05	0.00269	CbGeAlD
Doxepin—ADRA1A—head—epilepsy syndrome	6.18e-05	0.00263	CbGeAlD
Doxepin—CHRM3—central nervous system—epilepsy syndrome	6.14e-05	0.00262	CbGeAlD
Doxepin—HTR1A—central nervous system—epilepsy syndrome	6.12e-05	0.00261	CbGeAlD
Doxepin—SLC6A2—central nervous system—epilepsy syndrome	6.07e-05	0.00259	CbGeAlD
Doxepin—DRD2—head—epilepsy syndrome	6.06e-05	0.00258	CbGeAlD
Doxepin—CHRM2—brain—epilepsy syndrome	5.99e-05	0.00255	CbGeAlD
Doxepin—HTR1A—cerebellum—epilepsy syndrome	5.98e-05	0.00255	CbGeAlD
Doxepin—KCNH2—head—epilepsy syndrome	5.97e-05	0.00254	CbGeAlD
Doxepin—ADRA2A—medulla oblongata—epilepsy syndrome	5.93e-05	0.00253	CbGeAlD
Doxepin—ADRA2C—head—epilepsy syndrome	5.89e-05	0.00251	CbGeAlD
Doxepin—ADRA1A—nervous system—epilepsy syndrome	5.86e-05	0.0025	CbGeAlD
Doxepin—CYP2D6—telencephalon—epilepsy syndrome	5.85e-05	0.00249	CbGeAlD
Doxepin—HTR2C—brain—epilepsy syndrome	5.77e-05	0.00246	CbGeAlD
Doxepin—DRD2—nervous system—epilepsy syndrome	5.74e-05	0.00245	CbGeAlD
Doxepin—KCNH2—nervous system—epilepsy syndrome	5.66e-05	0.00241	CbGeAlD
Doxepin—ADRA1A—central nervous system—epilepsy syndrome	5.64e-05	0.0024	CbGeAlD
Doxepin—ADRA2C—nervous system—epilepsy syndrome	5.58e-05	0.00238	CbGeAlD
Doxepin—DRD2—central nervous system—epilepsy syndrome	5.53e-05	0.00236	CbGeAlD
Doxepin—ADRA1A—cerebellum—epilepsy syndrome	5.51e-05	0.00235	CbGeAlD
Doxepin—Amitriptyline—NTRK2—epilepsy syndrome	5.48e-05	0.0295	CrCbGaD
Doxepin—SLC6A4—brain—epilepsy syndrome	5.47e-05	0.00233	CbGeAlD
Doxepin—CHRM1—brain—epilepsy syndrome	5.45e-05	0.00232	CbGeAlD
Doxepin—KCNH2—central nervous system—epilepsy syndrome	5.45e-05	0.00232	CbGeAlD
Doxepin—HTR2B—brain—epilepsy syndrome	5.42e-05	0.00231	CbGeAlD
Doxepin—ADRA2A—midbrain—epilepsy syndrome	5.42e-05	0.00231	CbGeAlD
Doxepin—DRD2—cerebellum—epilepsy syndrome	5.4e-05	0.0023	CbGeAlD
Doxepin—ADRA2C—central nervous system—epilepsy syndrome	5.38e-05	0.00229	CbGeAlD
Doxepin—Orphenadrine—SCN9A—epilepsy syndrome	5.36e-05	0.0288	CrCbGaD
Doxepin—KCNH2—cerebellum—epilepsy syndrome	5.33e-05	0.00227	CbGeAlD
Doxepin—ADRA2A—spinal cord—epilepsy syndrome	5.29e-05	0.00225	CbGeAlD
Doxepin—ADRA2C—cerebellum—epilepsy syndrome	5.25e-05	0.00224	CbGeAlD
Doxepin—HTR2A—medulla oblongata—epilepsy syndrome	5.04e-05	0.00215	CbGeAlD
Doxepin—Orphenadrine—SCN4A—epilepsy syndrome	4.92e-05	0.0265	CrCbGaD
Doxepin—CHRM3—brain—epilepsy syndrome	4.88e-05	0.00208	CbGeAlD
Doxepin—HTR1A—brain—epilepsy syndrome	4.86e-05	0.00207	CbGeAlD
Doxepin—SLC6A2—brain—epilepsy syndrome	4.82e-05	0.00205	CbGeAlD
Doxepin—HRH1—head—epilepsy syndrome	4.78e-05	0.00204	CbGeAlD
Doxepin—ADRA2A—head—epilepsy syndrome	4.7e-05	0.002	CbGeAlD
Doxepin—HTR2A—midbrain—epilepsy syndrome	4.61e-05	0.00196	CbGeAlD
Doxepin—ABCB1—forebrain—epilepsy syndrome	4.57e-05	0.00195	CbGeAlD
Doxepin—HRH1—nervous system—epilepsy syndrome	4.54e-05	0.00193	CbGeAlD
Doxepin—Dimetindene—CHRM2—epilepsy syndrome	4.51e-05	0.0243	CrCbGaD
Doxepin—HTR2A—spinal cord—epilepsy syndrome	4.5e-05	0.00192	CbGeAlD
Doxepin—ADRA1A—brain—epilepsy syndrome	4.48e-05	0.00191	CbGeAlD
Doxepin—ADRA2A—nervous system—epilepsy syndrome	4.46e-05	0.0019	CbGeAlD
Doxepin—DRD2—brain—epilepsy syndrome	4.39e-05	0.00187	CbGeAlD
Doxepin—HRH1—central nervous system—epilepsy syndrome	4.37e-05	0.00186	CbGeAlD
Doxepin—KCNH2—brain—epilepsy syndrome	4.33e-05	0.00184	CbGeAlD
Doxepin—ADRA2A—central nervous system—epilepsy syndrome	4.29e-05	0.00183	CbGeAlD
Doxepin—ADRA2C—brain—epilepsy syndrome	4.27e-05	0.00182	CbGeAlD
Doxepin—ABCB1—telencephalon—epilepsy syndrome	4.21e-05	0.00179	CbGeAlD
Doxepin—ADRA2A—cerebellum—epilepsy syndrome	4.19e-05	0.00179	CbGeAlD
Doxepin—HTR2A—head—epilepsy syndrome	4e-05	0.0017	CbGeAlD
Doxepin—HTR2A—nervous system—epilepsy syndrome	3.79e-05	0.00161	CbGeAlD
Doxepin—HTR2A—central nervous system—epilepsy syndrome	3.65e-05	0.00155	CbGeAlD
Doxepin—CYP2D6—head—epilepsy syndrome	3.64e-05	0.00155	CbGeAlD
Doxepin—Orphenadrine—SCN1A—epilepsy syndrome	3.6e-05	0.0194	CrCbGaD
Doxepin—HTR2A—cerebellum—epilepsy syndrome	3.56e-05	0.00152	CbGeAlD
Doxepin—CYP3A4—nervous system—epilepsy syndrome	3.51e-05	0.00149	CbGeAlD
Doxepin—HRH1—brain—epilepsy syndrome	3.47e-05	0.00148	CbGeAlD
Doxepin—CYP2D6—nervous system—epilepsy syndrome	3.45e-05	0.00147	CbGeAlD
Doxepin—ADRA2A—brain—epilepsy syndrome	3.41e-05	0.00145	CbGeAlD
Doxepin—CYP3A4—central nervous system—epilepsy syndrome	3.38e-05	0.00144	CbGeAlD
Doxepin—CYP2D6—central nervous system—epilepsy syndrome	3.32e-05	0.00142	CbGeAlD
Doxepin—ABCB1—medulla oblongata—epilepsy syndrome	3.3e-05	0.00141	CbGeAlD
Doxepin—CYP2D6—cerebellum—epilepsy syndrome	3.25e-05	0.00138	CbGeAlD
Doxepin—ABCB1—midbrain—epilepsy syndrome	3.02e-05	0.00129	CbGeAlD
Doxepin—ABCB1—spinal cord—epilepsy syndrome	2.95e-05	0.00126	CbGeAlD
Doxepin—HTR2A—brain—epilepsy syndrome	2.9e-05	0.00123	CbGeAlD
Doxepin—Chlorprothixene—CHRM3—epilepsy syndrome	2.8e-05	0.0151	CrCbGaD
Doxepin—Nortriptyline—CHRM3—epilepsy syndrome	2.75e-05	0.0148	CrCbGaD
Doxepin—CYP2D6—brain—epilepsy syndrome	2.64e-05	0.00112	CbGeAlD
Doxepin—ABCB1—head—epilepsy syndrome	2.62e-05	0.00112	CbGeAlD
Doxepin—Chlorprothixene—CHRM1—epilepsy syndrome	2.61e-05	0.0141	CrCbGaD
Doxepin—Nortriptyline—CHRM1—epilepsy syndrome	2.56e-05	0.0138	CrCbGaD
Doxepin—Promethazine—CHRM3—epilepsy syndrome	2.49e-05	0.0134	CrCbGaD
Doxepin—ABCB1—nervous system—epilepsy syndrome	2.48e-05	0.00106	CbGeAlD
Doxepin—ABCB1—central nervous system—epilepsy syndrome	2.39e-05	0.00102	CbGeAlD
Doxepin—ABCB1—cerebellum—epilepsy syndrome	2.34e-05	0.000996	CbGeAlD
Doxepin—Promethazine—CHRM1—epilepsy syndrome	2.32e-05	0.0125	CrCbGaD
Doxepin—Thiothixene—ADRA2A—epilepsy syndrome	2.31e-05	0.0125	CrCbGaD
Doxepin—Oxcarbazepine—CYP2C19—epilepsy syndrome	2.3e-05	0.0124	CrCbGaD
Doxepin—Desipramine—CHRM3—epilepsy syndrome	2.26e-05	0.0122	CrCbGaD
Doxepin—Tripelennamine—CYP2D6—epilepsy syndrome	2.24e-05	0.0121	CrCbGaD
Doxepin—Amitriptyline—OPRD1—epilepsy syndrome	2.24e-05	0.0121	CrCbGaD
Doxepin—Promazine—CHRM3—epilepsy syndrome	2.19e-05	0.0118	CrCbGaD
Doxepin—Chlorprothixene—CHRM2—epilepsy syndrome	2.13e-05	0.0115	CrCbGaD
Doxepin—Desipramine—CHRM1—epilepsy syndrome	2.11e-05	0.0114	CrCbGaD
Doxepin—Nortriptyline—CHRM2—epilepsy syndrome	2.09e-05	0.0113	CrCbGaD
Doxepin—Promazine—CHRM1—epilepsy syndrome	2.04e-05	0.011	CrCbGaD
Doxepin—Cyclobenzaprine—HTR2A—epilepsy syndrome	2.04e-05	0.011	CrCbGaD
Doxepin—Diphenhydramine—CHRM2—epilepsy syndrome	1.93e-05	0.0104	CrCbGaD
Doxepin—Imipramine—CHRM3—epilepsy syndrome	1.92e-05	0.0103	CrCbGaD
Doxepin—Amitriptyline—CHRM3—epilepsy syndrome	1.91e-05	0.0103	CrCbGaD
Doxepin—ABCB1—brain—epilepsy syndrome	1.9e-05	0.000809	CbGeAlD
Doxepin—Promethazine—CHRM2—epilepsy syndrome	1.9e-05	0.0102	CrCbGaD
Doxepin—Cyclobenzaprine—CYP2D6—epilepsy syndrome	1.87e-05	0.01	CrCbGaD
Doxepin—Orphenadrine—CHRM2—epilepsy syndrome	1.83e-05	0.00985	CrCbGaD
Doxepin—Clomipramine—ADRA2A—epilepsy syndrome	1.83e-05	0.00984	CrCbGaD
Doxepin—Imipramine—CHRM1—epilepsy syndrome	1.79e-05	0.00964	CrCbGaD
Doxepin—Amitriptyline—CHRM1—epilepsy syndrome	1.78e-05	0.00958	CrCbGaD
Doxepin—Desipramine—CHRM2—epilepsy syndrome	1.72e-05	0.00928	CrCbGaD
Doxepin—Amitriptyline—OPRM1—epilepsy syndrome	1.72e-05	0.00924	CrCbGaD
Doxepin—Trimipramine—ADRA2A—epilepsy syndrome	1.68e-05	0.00906	CrCbGaD
Doxepin—Promazine—CHRM2—epilepsy syndrome	1.67e-05	0.00899	CrCbGaD
Doxepin—Imipramine—CHRM2—epilepsy syndrome	1.46e-05	0.00787	CrCbGaD
Doxepin—Imipramine—HTR7—epilepsy syndrome	1.45e-05	0.00783	CrCbGaD
Doxepin—Amitriptyline—CHRM2—epilepsy syndrome	1.45e-05	0.00782	CrCbGaD
Doxepin—Amitriptyline—HTR7—epilepsy syndrome	1.45e-05	0.00778	CrCbGaD
Doxepin—Promazine—ADRA2A—epilepsy syndrome	1.42e-05	0.00767	CrCbGaD
Doxepin—Clomipramine—SLC6A4—epilepsy syndrome	1.39e-05	0.00751	CrCbGaD
Doxepin—Nortriptyline—SLC6A4—epilepsy syndrome	1.36e-05	0.00734	CrCbGaD
Doxepin—Thiothixene—HTR2A—epilepsy syndrome	1.36e-05	0.0073	CrCbGaD
Doxepin—Clomipramine—CYP2C19—epilepsy syndrome	1.32e-05	0.00712	CrCbGaD
Doxepin—Nortriptyline—CYP2C19—epilepsy syndrome	1.29e-05	0.00696	CrCbGaD
Doxepin—Diarrhoea—Clonazepam—epilepsy syndrome	1.29e-05	0.000158	CcSEcCtD
Doxepin—Anaemia—Gabapentin—epilepsy syndrome	1.29e-05	0.000158	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.28e-05	0.000157	CcSEcCtD
Doxepin—Trimipramine—SLC6A4—epilepsy syndrome	1.28e-05	0.00691	CrCbGaD
Doxepin—Hypotension—Valproic Acid—epilepsy syndrome	1.28e-05	0.000157	CcSEcCtD
Doxepin—Asthenia—Carbamazepine—epilepsy syndrome	1.28e-05	0.000157	CcSEcCtD
Doxepin—Agitation—Gabapentin—epilepsy syndrome	1.28e-05	0.000157	CcSEcCtD
Doxepin—Diarrhoea—Phenytoin—epilepsy syndrome	1.28e-05	0.000157	CcSEcCtD
Doxepin—Discomfort—Pregabalin—epilepsy syndrome	1.28e-05	0.000156	CcSEcCtD
Doxepin—Oxcarbazepine—ALB—epilepsy syndrome	1.28e-05	0.00687	CrCbGaD
Doxepin—Nausea—Fosphenytoin—epilepsy syndrome	1.28e-05	0.000156	CcSEcCtD
Doxepin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.27e-05	0.000156	CcSEcCtD
Doxepin—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.27e-05	0.000156	CcSEcCtD
Doxepin—Vomiting—Felbamate—epilepsy syndrome	1.27e-05	0.000155	CcSEcCtD
Doxepin—Dry mouth—Pregabalin—epilepsy syndrome	1.26e-05	0.000155	CcSEcCtD
Doxepin—Pruritus—Carbamazepine—epilepsy syndrome	1.26e-05	0.000155	CcSEcCtD
Doxepin—Rash—Felbamate—epilepsy syndrome	1.26e-05	0.000154	CcSEcCtD
Doxepin—Eye disorder—Topiramate—epilepsy syndrome	1.26e-05	0.000154	CcSEcCtD
Doxepin—Dermatitis—Felbamate—epilepsy syndrome	1.26e-05	0.000154	CcSEcCtD
Doxepin—Malaise—Gabapentin—epilepsy syndrome	1.26e-05	0.000154	CcSEcCtD
Doxepin—Tinnitus—Topiramate—epilepsy syndrome	1.25e-05	0.000154	CcSEcCtD
Doxepin—Vertigo—Gabapentin—epilepsy syndrome	1.25e-05	0.000153	CcSEcCtD
Doxepin—Headache—Felbamate—epilepsy syndrome	1.25e-05	0.000153	CcSEcCtD
Doxepin—Confusional state—Pregabalin—epilepsy syndrome	1.25e-05	0.000153	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.25e-05	0.000153	CcSEcCtD
Doxepin—Cardiac disorder—Topiramate—epilepsy syndrome	1.25e-05	0.000153	CcSEcCtD
Doxepin—Flushing—Topiramate—epilepsy syndrome	1.25e-05	0.000153	CcSEcCtD
Doxepin—Syncope—Gabapentin—epilepsy syndrome	1.25e-05	0.000153	CcSEcCtD
Doxepin—Leukopenia—Gabapentin—epilepsy syndrome	1.25e-05	0.000153	CcSEcCtD
Doxepin—Dizziness—Clonazepam—epilepsy syndrome	1.25e-05	0.000152	CcSEcCtD
Doxepin—Nausea—Vigabatrin—epilepsy syndrome	1.24e-05	0.000152	CcSEcCtD
Doxepin—Vomiting—Zonisamide—epilepsy syndrome	1.24e-05	0.000152	CcSEcCtD
Doxepin—Insomnia—Valproic Acid—epilepsy syndrome	1.24e-05	0.000152	CcSEcCtD
Doxepin—Thiothixene—CYP2D6—epilepsy syndrome	1.24e-05	0.00667	CrCbGaD
Doxepin—Amitriptyline—ADRA2A—epilepsy syndrome	1.24e-05	0.00667	CrCbGaD
Doxepin—Oedema—Pregabalin—epilepsy syndrome	1.24e-05	0.000152	CcSEcCtD
Doxepin—Asthenia—Lamotrigine—epilepsy syndrome	1.24e-05	0.000152	CcSEcCtD
Doxepin—Dizziness—Phenytoin—epilepsy syndrome	1.24e-05	0.000151	CcSEcCtD
Doxepin—Rash—Zonisamide—epilepsy syndrome	1.23e-05	0.000151	CcSEcCtD
Doxepin—Infection—Pregabalin—epilepsy syndrome	1.23e-05	0.000151	CcSEcCtD
Doxepin—Paraesthesia—Valproic Acid—epilepsy syndrome	1.23e-05	0.000151	CcSEcCtD
Doxepin—Palpitations—Gabapentin—epilepsy syndrome	1.23e-05	0.000151	CcSEcCtD
Doxepin—Dermatitis—Zonisamide—epilepsy syndrome	1.23e-05	0.000151	CcSEcCtD
Doxepin—Dizziness—Oxcarbazepine—epilepsy syndrome	1.23e-05	0.000151	CcSEcCtD
Doxepin—Nausea—Diazepam—epilepsy syndrome	1.22e-05	0.00015	CcSEcCtD
Doxepin—Loss of consciousness—Gabapentin—epilepsy syndrome	1.22e-05	0.00015	CcSEcCtD
Doxepin—Headache—Zonisamide—epilepsy syndrome	1.22e-05	0.00015	CcSEcCtD
Doxepin—Dyspnoea—Valproic Acid—epilepsy syndrome	1.22e-05	0.00015	CcSEcCtD
Doxepin—Diarrhoea—Carbamazepine—epilepsy syndrome	1.22e-05	0.00015	CcSEcCtD
Doxepin—Angiopathy—Topiramate—epilepsy syndrome	1.22e-05	0.00015	CcSEcCtD
Doxepin—Pruritus—Lamotrigine—epilepsy syndrome	1.22e-05	0.000149	CcSEcCtD
Doxepin—Shock—Pregabalin—epilepsy syndrome	1.22e-05	0.000149	CcSEcCtD
Doxepin—Somnolence—Valproic Acid—epilepsy syndrome	1.22e-05	0.000149	CcSEcCtD
Doxepin—Trimipramine—CYP2C19—epilepsy syndrome	1.22e-05	0.00655	CrCbGaD
Doxepin—Immune system disorder—Topiramate—epilepsy syndrome	1.22e-05	0.000149	CcSEcCtD
Doxepin—Nervous system disorder—Pregabalin—epilepsy syndrome	1.22e-05	0.000149	CcSEcCtD
Doxepin—Cough—Gabapentin—epilepsy syndrome	1.22e-05	0.000149	CcSEcCtD
Doxepin—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.21e-05	0.000149	CcSEcCtD
Doxepin—Mediastinal disorder—Topiramate—epilepsy syndrome	1.21e-05	0.000149	CcSEcCtD
Doxepin—Tachycardia—Pregabalin—epilepsy syndrome	1.21e-05	0.000148	CcSEcCtD
Doxepin—Chills—Topiramate—epilepsy syndrome	1.21e-05	0.000148	CcSEcCtD
Doxepin—Dyspepsia—Valproic Acid—epilepsy syndrome	1.21e-05	0.000148	CcSEcCtD
Doxepin—Convulsion—Gabapentin—epilepsy syndrome	1.21e-05	0.000148	CcSEcCtD
Doxepin—Skin disorder—Pregabalin—epilepsy syndrome	1.2e-05	0.000147	CcSEcCtD
Doxepin—Hypertension—Gabapentin—epilepsy syndrome	1.2e-05	0.000147	CcSEcCtD
Doxepin—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.2e-05	0.000147	CcSEcCtD
Doxepin—Vomiting—Clonazepam—epilepsy syndrome	1.2e-05	0.000147	CcSEcCtD
Doxepin—Diphenhydramine—CYP2C19—epilepsy syndrome	1.19e-05	0.00643	CrCbGaD
Doxepin—Decreased appetite—Valproic Acid—epilepsy syndrome	1.19e-05	0.000146	CcSEcCtD
Doxepin—Alopecia—Topiramate—epilepsy syndrome	1.19e-05	0.000146	CcSEcCtD
Doxepin—Vomiting—Phenytoin—epilepsy syndrome	1.19e-05	0.000146	CcSEcCtD
Doxepin—Rash—Clonazepam—epilepsy syndrome	1.19e-05	0.000145	CcSEcCtD
Doxepin—Dermatitis—Clonazepam—epilepsy syndrome	1.19e-05	0.000145	CcSEcCtD
Doxepin—Myalgia—Gabapentin—epilepsy syndrome	1.19e-05	0.000145	CcSEcCtD
Doxepin—Chest pain—Gabapentin—epilepsy syndrome	1.19e-05	0.000145	CcSEcCtD
Doxepin—Arthralgia—Gabapentin—epilepsy syndrome	1.19e-05	0.000145	CcSEcCtD
Doxepin—Nausea—Felbamate—epilepsy syndrome	1.19e-05	0.000145	CcSEcCtD
Doxepin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.18e-05	0.000145	CcSEcCtD
Doxepin—Vomiting—Oxcarbazepine—epilepsy syndrome	1.18e-05	0.000145	CcSEcCtD
Doxepin—Fatigue—Valproic Acid—epilepsy syndrome	1.18e-05	0.000145	CcSEcCtD
Doxepin—Anxiety—Gabapentin—epilepsy syndrome	1.18e-05	0.000145	CcSEcCtD
Doxepin—Anorexia—Pregabalin—epilepsy syndrome	1.18e-05	0.000145	CcSEcCtD
Doxepin—Dizziness—Carbamazepine—epilepsy syndrome	1.18e-05	0.000145	CcSEcCtD
Doxepin—Diarrhoea—Lamotrigine—epilepsy syndrome	1.18e-05	0.000145	CcSEcCtD
Doxepin—Headache—Clonazepam—epilepsy syndrome	1.18e-05	0.000144	CcSEcCtD
Doxepin—Rash—Phenytoin—epilepsy syndrome	1.18e-05	0.000144	CcSEcCtD
Doxepin—Mental disorder—Topiramate—epilepsy syndrome	1.18e-05	0.000144	CcSEcCtD
Doxepin—Dermatitis—Phenytoin—epilepsy syndrome	1.18e-05	0.000144	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.18e-05	0.000144	CcSEcCtD
Doxepin—Rash—Oxcarbazepine—epilepsy syndrome	1.17e-05	0.000144	CcSEcCtD
Doxepin—Pain—Valproic Acid—epilepsy syndrome	1.17e-05	0.000144	CcSEcCtD
Doxepin—Constipation—Valproic Acid—epilepsy syndrome	1.17e-05	0.000144	CcSEcCtD
Doxepin—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.17e-05	0.000143	CcSEcCtD
Doxepin—Headache—Phenytoin—epilepsy syndrome	1.17e-05	0.000143	CcSEcCtD
Doxepin—Malnutrition—Topiramate—epilepsy syndrome	1.17e-05	0.000143	CcSEcCtD
Doxepin—Erythema—Topiramate—epilepsy syndrome	1.17e-05	0.000143	CcSEcCtD
Doxepin—Discomfort—Gabapentin—epilepsy syndrome	1.17e-05	0.000143	CcSEcCtD
Doxepin—Headache—Oxcarbazepine—epilepsy syndrome	1.17e-05	0.000143	CcSEcCtD
Doxepin—Nausea—Zonisamide—epilepsy syndrome	1.16e-05	0.000142	CcSEcCtD
Doxepin—Dry mouth—Gabapentin—epilepsy syndrome	1.16e-05	0.000142	CcSEcCtD
Doxepin—Hypotension—Pregabalin—epilepsy syndrome	1.16e-05	0.000142	CcSEcCtD
Doxepin—Flatulence—Topiramate—epilepsy syndrome	1.15e-05	0.000141	CcSEcCtD
Doxepin—Tension—Topiramate—epilepsy syndrome	1.15e-05	0.000141	CcSEcCtD
Doxepin—Dysgeusia—Topiramate—epilepsy syndrome	1.15e-05	0.00014	CcSEcCtD
Doxepin—Confusional state—Gabapentin—epilepsy syndrome	1.15e-05	0.00014	CcSEcCtD
Doxepin—Dizziness—Lamotrigine—epilepsy syndrome	1.14e-05	0.00014	CcSEcCtD
Doxepin—Nervousness—Topiramate—epilepsy syndrome	1.14e-05	0.000139	CcSEcCtD
Doxepin—Oedema—Gabapentin—epilepsy syndrome	1.14e-05	0.000139	CcSEcCtD
Doxepin—Vomiting—Carbamazepine—epilepsy syndrome	1.14e-05	0.000139	CcSEcCtD
Doxepin—Back pain—Topiramate—epilepsy syndrome	1.13e-05	0.000139	CcSEcCtD
Doxepin—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.13e-05	0.000138	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.13e-05	0.000138	CcSEcCtD
Doxepin—Infection—Gabapentin—epilepsy syndrome	1.13e-05	0.000138	CcSEcCtD
Doxepin—Muscle spasms—Topiramate—epilepsy syndrome	1.13e-05	0.000138	CcSEcCtD
Doxepin—Rash—Carbamazepine—epilepsy syndrome	1.13e-05	0.000138	CcSEcCtD
Doxepin—Dermatitis—Carbamazepine—epilepsy syndrome	1.12e-05	0.000138	CcSEcCtD
Doxepin—Desipramine—SLC6A4—epilepsy syndrome	1.12e-05	0.00604	CrCbGaD
Doxepin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.12e-05	0.000137	CcSEcCtD
Doxepin—Insomnia—Pregabalin—epilepsy syndrome	1.12e-05	0.000137	CcSEcCtD
Doxepin—Nausea—Clonazepam—epilepsy syndrome	1.12e-05	0.000137	CcSEcCtD
Doxepin—Headache—Carbamazepine—epilepsy syndrome	1.12e-05	0.000137	CcSEcCtD
Doxepin—Shock—Gabapentin—epilepsy syndrome	1.12e-05	0.000137	CcSEcCtD
Doxepin—Nervous system disorder—Gabapentin—epilepsy syndrome	1.11e-05	0.000136	CcSEcCtD
Doxepin—Paraesthesia—Pregabalin—epilepsy syndrome	1.11e-05	0.000136	CcSEcCtD
Doxepin—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.11e-05	0.000136	CcSEcCtD
Doxepin—Nausea—Phenytoin—epilepsy syndrome	1.11e-05	0.000136	CcSEcCtD
Doxepin—Tachycardia—Gabapentin—epilepsy syndrome	1.11e-05	0.000136	CcSEcCtD
Doxepin—Dyspnoea—Pregabalin—epilepsy syndrome	1.11e-05	0.000135	CcSEcCtD
Doxepin—Nausea—Oxcarbazepine—epilepsy syndrome	1.11e-05	0.000135	CcSEcCtD
Doxepin—Vision blurred—Topiramate—epilepsy syndrome	1.1e-05	0.000135	CcSEcCtD
Doxepin—Skin disorder—Gabapentin—epilepsy syndrome	1.1e-05	0.000135	CcSEcCtD
Doxepin—Somnolence—Pregabalin—epilepsy syndrome	1.1e-05	0.000135	CcSEcCtD
Doxepin—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.1e-05	0.000135	CcSEcCtD
Doxepin—Tremor—Topiramate—epilepsy syndrome	1.1e-05	0.000134	CcSEcCtD
Doxepin—Vomiting—Lamotrigine—epilepsy syndrome	1.1e-05	0.000134	CcSEcCtD
Doxepin—Urticaria—Valproic Acid—epilepsy syndrome	1.09e-05	0.000133	CcSEcCtD
Doxepin—Rash—Lamotrigine—epilepsy syndrome	1.09e-05	0.000133	CcSEcCtD
Doxepin—Ill-defined disorder—Topiramate—epilepsy syndrome	1.09e-05	0.000133	CcSEcCtD
Doxepin—Dermatitis—Lamotrigine—epilepsy syndrome	1.09e-05	0.000133	CcSEcCtD
Doxepin—Body temperature increased—Valproic Acid—epilepsy syndrome	1.08e-05	0.000133	CcSEcCtD
Doxepin—Abdominal pain—Valproic Acid—epilepsy syndrome	1.08e-05	0.000133	CcSEcCtD
Doxepin—Anorexia—Gabapentin—epilepsy syndrome	1.08e-05	0.000133	CcSEcCtD
Doxepin—Anaemia—Topiramate—epilepsy syndrome	1.08e-05	0.000133	CcSEcCtD
Doxepin—Headache—Lamotrigine—epilepsy syndrome	1.08e-05	0.000132	CcSEcCtD
Doxepin—Decreased appetite—Pregabalin—epilepsy syndrome	1.08e-05	0.000132	CcSEcCtD
Doxepin—Agitation—Topiramate—epilepsy syndrome	1.08e-05	0.000132	CcSEcCtD
Doxepin—Clomipramine—HTR2A—epilepsy syndrome	1.07e-05	0.00577	CrCbGaD
Doxepin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.07e-05	0.000131	CcSEcCtD
Doxepin—Fatigue—Pregabalin—epilepsy syndrome	1.07e-05	0.000131	CcSEcCtD
Doxepin—Chlorprothixene—HTR2A—epilepsy syndrome	1.07e-05	0.00574	CrCbGaD
Doxepin—Desipramine—CYP2C19—epilepsy syndrome	1.06e-05	0.00573	CrCbGaD
Doxepin—Hypotension—Gabapentin—epilepsy syndrome	1.06e-05	0.00013	CcSEcCtD
Doxepin—Nausea—Carbamazepine—epilepsy syndrome	1.06e-05	0.00013	CcSEcCtD
Doxepin—Pain—Pregabalin—epilepsy syndrome	1.06e-05	0.00013	CcSEcCtD
Doxepin—Constipation—Pregabalin—epilepsy syndrome	1.06e-05	0.00013	CcSEcCtD
Doxepin—Malaise—Topiramate—epilepsy syndrome	1.06e-05	0.000129	CcSEcCtD
Doxepin—Vertigo—Topiramate—epilepsy syndrome	1.05e-05	0.000129	CcSEcCtD
Doxepin—Syncope—Topiramate—epilepsy syndrome	1.05e-05	0.000129	CcSEcCtD
Doxepin—Leukopenia—Topiramate—epilepsy syndrome	1.05e-05	0.000128	CcSEcCtD
Doxepin—Nortriptyline—HTR2A—epilepsy syndrome	1.05e-05	0.00564	CrCbGaD
Doxepin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.04e-05	0.000127	CcSEcCtD
Doxepin—Palpitations—Topiramate—epilepsy syndrome	1.04e-05	0.000127	CcSEcCtD
Doxepin—Promazine—CYP2C19—epilepsy syndrome	1.03e-05	0.00555	CrCbGaD
Doxepin—Loss of consciousness—Topiramate—epilepsy syndrome	1.03e-05	0.000126	CcSEcCtD
Doxepin—Insomnia—Gabapentin—epilepsy syndrome	1.03e-05	0.000126	CcSEcCtD
Doxepin—Nausea—Lamotrigine—epilepsy syndrome	1.02e-05	0.000125	CcSEcCtD
Doxepin—Cough—Topiramate—epilepsy syndrome	1.02e-05	0.000125	CcSEcCtD
Doxepin—Feeling abnormal—Pregabalin—epilepsy syndrome	1.02e-05	0.000125	CcSEcCtD
Doxepin—Paraesthesia—Gabapentin—epilepsy syndrome	1.02e-05	0.000125	CcSEcCtD
Doxepin—Convulsion—Topiramate—epilepsy syndrome	1.02e-05	0.000124	CcSEcCtD
Doxepin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.01e-05	0.000124	CcSEcCtD
Doxepin—Dyspnoea—Gabapentin—epilepsy syndrome	1.01e-05	0.000124	CcSEcCtD
Doxepin—Hypertension—Topiramate—epilepsy syndrome	1.01e-05	0.000124	CcSEcCtD
Doxepin—Somnolence—Gabapentin—epilepsy syndrome	1.01e-05	0.000124	CcSEcCtD
Doxepin—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.01e-05	0.000124	CcSEcCtD
Doxepin—Dyspepsia—Gabapentin—epilepsy syndrome	1e-05	0.000123	CcSEcCtD
Doxepin—Myalgia—Topiramate—epilepsy syndrome	9.97e-06	0.000122	CcSEcCtD
Doxepin—Arthralgia—Topiramate—epilepsy syndrome	9.97e-06	0.000122	CcSEcCtD
Doxepin—Chest pain—Topiramate—epilepsy syndrome	9.97e-06	0.000122	CcSEcCtD
Doxepin—Anxiety—Topiramate—epilepsy syndrome	9.94e-06	0.000122	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	9.91e-06	0.000121	CcSEcCtD
Doxepin—Decreased appetite—Gabapentin—epilepsy syndrome	9.88e-06	0.000121	CcSEcCtD
Doxepin—Trimipramine—HTR2A—epilepsy syndrome	9.86e-06	0.00531	CrCbGaD
Doxepin—Discomfort—Topiramate—epilepsy syndrome	9.86e-06	0.000121	CcSEcCtD
Doxepin—Urticaria—Pregabalin—epilepsy syndrome	9.85e-06	0.000121	CcSEcCtD
Doxepin—Asthenia—Valproic Acid—epilepsy syndrome	9.84e-06	0.00012	CcSEcCtD
Doxepin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.81e-06	0.00012	CcSEcCtD
Doxepin—Clomipramine—CYP2D6—epilepsy syndrome	9.8e-06	0.00528	CrCbGaD
Doxepin—Fatigue—Gabapentin—epilepsy syndrome	9.8e-06	0.00012	CcSEcCtD
Doxepin—Abdominal pain—Pregabalin—epilepsy syndrome	9.8e-06	0.00012	CcSEcCtD
Doxepin—Body temperature increased—Pregabalin—epilepsy syndrome	9.8e-06	0.00012	CcSEcCtD
Doxepin—Dry mouth—Topiramate—epilepsy syndrome	9.76e-06	0.000119	CcSEcCtD
Doxepin—Pain—Gabapentin—epilepsy syndrome	9.72e-06	0.000119	CcSEcCtD
Doxepin—Constipation—Gabapentin—epilepsy syndrome	9.72e-06	0.000119	CcSEcCtD
Doxepin—Pruritus—Valproic Acid—epilepsy syndrome	9.7e-06	0.000119	CcSEcCtD
Doxepin—Confusional state—Topiramate—epilepsy syndrome	9.64e-06	0.000118	CcSEcCtD
Doxepin—Nortriptyline—CYP2D6—epilepsy syndrome	9.58e-06	0.00516	CrCbGaD
Doxepin—Oedema—Topiramate—epilepsy syndrome	9.56e-06	0.000117	CcSEcCtD
Doxepin—Imipramine—SLC6A4—epilepsy syndrome	9.51e-06	0.00512	CrCbGaD
Doxepin—Infection—Topiramate—epilepsy syndrome	9.5e-06	0.000116	CcSEcCtD
Doxepin—Promethazine—HTR2A—epilepsy syndrome	9.49e-06	0.00511	CrCbGaD
Doxepin—Amitriptyline—SLC6A4—epilepsy syndrome	9.46e-06	0.00509	CrCbGaD
Doxepin—Shock—Topiramate—epilepsy syndrome	9.41e-06	0.000115	CcSEcCtD
Doxepin—Diarrhoea—Valproic Acid—epilepsy syndrome	9.38e-06	0.000115	CcSEcCtD
Doxepin—Nervous system disorder—Topiramate—epilepsy syndrome	9.38e-06	0.000115	CcSEcCtD
Doxepin—Feeling abnormal—Gabapentin—epilepsy syndrome	9.37e-06	0.000115	CcSEcCtD
Doxepin—Thrombocytopenia—Topiramate—epilepsy syndrome	9.36e-06	0.000115	CcSEcCtD
Doxepin—Tachycardia—Topiramate—epilepsy syndrome	9.33e-06	0.000114	CcSEcCtD
Doxepin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	9.29e-06	0.000114	CcSEcCtD
Doxepin—Skin disorder—Topiramate—epilepsy syndrome	9.29e-06	0.000114	CcSEcCtD
Doxepin—Thiothixene—ALB—epilepsy syndrome	9.28e-06	0.00499	CrCbGaD
Doxepin—Hyperhidrosis—Topiramate—epilepsy syndrome	9.24e-06	0.000113	CcSEcCtD
Doxepin—Hypersensitivity—Pregabalin—epilepsy syndrome	9.13e-06	0.000112	CcSEcCtD
Doxepin—Anorexia—Topiramate—epilepsy syndrome	9.11e-06	0.000112	CcSEcCtD
Doxepin—Dizziness—Valproic Acid—epilepsy syndrome	9.07e-06	0.000111	CcSEcCtD
Doxepin—Urticaria—Gabapentin—epilepsy syndrome	9.03e-06	0.000111	CcSEcCtD
Doxepin—Imipramine—CYP2C19—epilepsy syndrome	9.02e-06	0.00486	CrCbGaD
Doxepin—Trimipramine—CYP2D6—epilepsy syndrome	9.02e-06	0.00485	CrCbGaD
Doxepin—Abdominal pain—Gabapentin—epilepsy syndrome	8.98e-06	0.00011	CcSEcCtD
Doxepin—Body temperature increased—Gabapentin—epilepsy syndrome	8.98e-06	0.00011	CcSEcCtD
Doxepin—Amitriptyline—CYP2C19—epilepsy syndrome	8.96e-06	0.00483	CrCbGaD
Doxepin—Hypotension—Topiramate—epilepsy syndrome	8.94e-06	0.000109	CcSEcCtD
Doxepin—Asthenia—Pregabalin—epilepsy syndrome	8.89e-06	0.000109	CcSEcCtD
Doxepin—Diphenhydramine—CYP2D6—epilepsy syndrome	8.85e-06	0.00477	CrCbGaD
Doxepin—Pruritus—Pregabalin—epilepsy syndrome	8.77e-06	0.000107	CcSEcCtD
Doxepin—Vomiting—Valproic Acid—epilepsy syndrome	8.72e-06	0.000107	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	8.71e-06	0.000107	CcSEcCtD
Doxepin—Promethazine—CYP2D6—epilepsy syndrome	8.68e-06	0.00467	CrCbGaD
Doxepin—Insomnia—Topiramate—epilepsy syndrome	8.65e-06	0.000106	CcSEcCtD
Doxepin—Rash—Valproic Acid—epilepsy syndrome	8.64e-06	0.000106	CcSEcCtD
Doxepin—Dermatitis—Valproic Acid—epilepsy syndrome	8.64e-06	0.000106	CcSEcCtD
Doxepin—Desipramine—HTR2A—epilepsy syndrome	8.62e-06	0.00464	CrCbGaD
Doxepin—Headache—Valproic Acid—epilepsy syndrome	8.59e-06	0.000105	CcSEcCtD
Doxepin—Paraesthesia—Topiramate—epilepsy syndrome	8.59e-06	0.000105	CcSEcCtD
Doxepin—Dyspnoea—Topiramate—epilepsy syndrome	8.52e-06	0.000104	CcSEcCtD
Doxepin—Somnolence—Topiramate—epilepsy syndrome	8.5e-06	0.000104	CcSEcCtD
Doxepin—Diarrhoea—Pregabalin—epilepsy syndrome	8.48e-06	0.000104	CcSEcCtD
Doxepin—Dyspepsia—Topiramate—epilepsy syndrome	8.42e-06	0.000103	CcSEcCtD
Doxepin—Hypersensitivity—Gabapentin—epilepsy syndrome	8.37e-06	0.000103	CcSEcCtD
Doxepin—Promazine—HTR2A—epilepsy syndrome	8.35e-06	0.0045	CrCbGaD
Doxepin—Decreased appetite—Topiramate—epilepsy syndrome	8.31e-06	0.000102	CcSEcCtD
Doxepin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.26e-06	0.000101	CcSEcCtD
Doxepin—Fatigue—Topiramate—epilepsy syndrome	8.24e-06	0.000101	CcSEcCtD
Doxepin—Dizziness—Pregabalin—epilepsy syndrome	8.2e-06	0.0001	CcSEcCtD
Doxepin—Pain—Topiramate—epilepsy syndrome	8.18e-06	0.0001	CcSEcCtD
Doxepin—Constipation—Topiramate—epilepsy syndrome	8.18e-06	0.0001	CcSEcCtD
Doxepin—Asthenia—Gabapentin—epilepsy syndrome	8.15e-06	9.98e-05	CcSEcCtD
Doxepin—Nausea—Valproic Acid—epilepsy syndrome	8.14e-06	9.97e-05	CcSEcCtD
Doxepin—Pruritus—Gabapentin—epilepsy syndrome	8.04e-06	9.85e-05	CcSEcCtD
Doxepin—Desipramine—CYP2D6—epilepsy syndrome	7.88e-06	0.00425	CrCbGaD
Doxepin—Vomiting—Pregabalin—epilepsy syndrome	7.88e-06	9.65e-05	CcSEcCtD
Doxepin—Feeling abnormal—Topiramate—epilepsy syndrome	7.88e-06	9.65e-05	CcSEcCtD
Doxepin—Gastrointestinal pain—Topiramate—epilepsy syndrome	7.82e-06	9.57e-05	CcSEcCtD
Doxepin—Rash—Pregabalin—epilepsy syndrome	7.82e-06	9.57e-05	CcSEcCtD
Doxepin—Dermatitis—Pregabalin—epilepsy syndrome	7.81e-06	9.56e-05	CcSEcCtD
Doxepin—Diarrhoea—Gabapentin—epilepsy syndrome	7.78e-06	9.52e-05	CcSEcCtD
Doxepin—Headache—Pregabalin—epilepsy syndrome	7.76e-06	9.51e-05	CcSEcCtD
Doxepin—Urticaria—Topiramate—epilepsy syndrome	7.6e-06	9.3e-05	CcSEcCtD
Doxepin—Abdominal pain—Topiramate—epilepsy syndrome	7.56e-06	9.26e-05	CcSEcCtD
Doxepin—Body temperature increased—Topiramate—epilepsy syndrome	7.56e-06	9.26e-05	CcSEcCtD
Doxepin—Dizziness—Gabapentin—epilepsy syndrome	7.52e-06	9.2e-05	CcSEcCtD
Doxepin—Nausea—Pregabalin—epilepsy syndrome	7.36e-06	9.01e-05	CcSEcCtD
Doxepin—Clomipramine—ALB—epilepsy syndrome	7.33e-06	0.00395	CrCbGaD
Doxepin—Imipramine—HTR2A—epilepsy syndrome	7.31e-06	0.00394	CrCbGaD
Doxepin—Amitriptyline—HTR2A—epilepsy syndrome	7.27e-06	0.00391	CrCbGaD
Doxepin—Vomiting—Gabapentin—epilepsy syndrome	7.23e-06	8.85e-05	CcSEcCtD
Doxepin—Rash—Gabapentin—epilepsy syndrome	7.17e-06	8.77e-05	CcSEcCtD
Doxepin—Nortriptyline—ALB—epilepsy syndrome	7.17e-06	0.00386	CrCbGaD
Doxepin—Dermatitis—Gabapentin—epilepsy syndrome	7.16e-06	8.77e-05	CcSEcCtD
Doxepin—Headache—Gabapentin—epilepsy syndrome	7.12e-06	8.72e-05	CcSEcCtD
Doxepin—Hypersensitivity—Topiramate—epilepsy syndrome	7.04e-06	8.63e-05	CcSEcCtD
Doxepin—Clomipramine—ABCB1—epilepsy syndrome	7e-06	0.00377	CrCbGaD
Doxepin—Chlorprothixene—ABCB1—epilepsy syndrome	6.97e-06	0.00375	CrCbGaD
Doxepin—Asthenia—Topiramate—epilepsy syndrome	6.86e-06	8.4e-05	CcSEcCtD
Doxepin—Pruritus—Topiramate—epilepsy syndrome	6.77e-06	8.28e-05	CcSEcCtD
Doxepin—Nausea—Gabapentin—epilepsy syndrome	6.75e-06	8.27e-05	CcSEcCtD
Doxepin—Imipramine—CYP2D6—epilepsy syndrome	6.69e-06	0.0036	CrCbGaD
Doxepin—Amitriptyline—CYP2D6—epilepsy syndrome	6.65e-06	0.00358	CrCbGaD
Doxepin—Diarrhoea—Topiramate—epilepsy syndrome	6.54e-06	8.01e-05	CcSEcCtD
Doxepin—Trimipramine—ABCB1—epilepsy syndrome	6.44e-06	0.00347	CrCbGaD
Doxepin—Dizziness—Topiramate—epilepsy syndrome	6.32e-06	7.74e-05	CcSEcCtD
Doxepin—Promethazine—ABCB1—epilepsy syndrome	6.2e-06	0.00334	CrCbGaD
Doxepin—Vomiting—Topiramate—epilepsy syndrome	6.08e-06	7.44e-05	CcSEcCtD
Doxepin—Rash—Topiramate—epilepsy syndrome	6.03e-06	7.38e-05	CcSEcCtD
Doxepin—Dermatitis—Topiramate—epilepsy syndrome	6.02e-06	7.38e-05	CcSEcCtD
Doxepin—Headache—Topiramate—epilepsy syndrome	5.99e-06	7.33e-05	CcSEcCtD
Doxepin—Nausea—Topiramate—epilepsy syndrome	5.68e-06	6.95e-05	CcSEcCtD
Doxepin—Desipramine—ABCB1—epilepsy syndrome	5.63e-06	0.00303	CrCbGaD
Doxepin—Amitriptyline—ALB—epilepsy syndrome	4.97e-06	0.00268	CrCbGaD
Doxepin—Imipramine—ABCB1—epilepsy syndrome	4.77e-06	0.00257	CrCbGaD
Doxepin—Amitriptyline—ABCB1—epilepsy syndrome	4.75e-06	0.00256	CrCbGaD
Doxepin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	4.31e-07	8.34e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	4.3e-07	8.33e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	4.28e-07	8.29e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.27e-07	8.27e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	4.27e-07	8.26e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.25e-07	8.23e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	4.24e-07	8.22e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—POMC—epilepsy syndrome	4.24e-07	8.2e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	4.23e-07	8.2e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—SRC—epilepsy syndrome	4.2e-07	8.14e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	4.17e-07	8.08e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	4.17e-07	8.07e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	4.16e-07	8.06e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.16e-07	8.06e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—POMC—epilepsy syndrome	4.16e-07	8.05e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.15e-07	8.03e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	4.15e-07	8.03e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	4.14e-07	8.03e-06	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	4.14e-07	8.01e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—ALB—epilepsy syndrome	4.13e-07	8.01e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	4.13e-07	8e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	4.13e-07	7.99e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	4.12e-07	7.98e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	4.1e-07	7.95e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	4.1e-07	7.94e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	4.1e-07	7.93e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	4.09e-07	7.93e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	4.08e-07	7.9e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	4.08e-07	7.9e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	4.07e-07	7.88e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	4.06e-07	7.87e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	4.06e-07	7.86e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	4.04e-07	7.83e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.04e-07	7.82e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	4.02e-07	7.79e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	4e-07	7.75e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	4e-07	7.75e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	4e-07	7.74e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	3.99e-07	7.73e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	3.98e-07	7.71e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.97e-07	7.69e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	3.97e-07	7.68e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	3.96e-07	7.67e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.94e-07	7.64e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.94e-07	7.63e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	3.94e-07	7.63e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	3.88e-07	7.52e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	3.87e-07	7.5e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	3.86e-07	7.48e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	3.86e-07	7.48e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	3.84e-07	7.43e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	3.83e-07	7.42e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.82e-07	7.39e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.8e-07	7.36e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	3.8e-07	7.36e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	3.79e-07	7.34e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	3.77e-07	7.3e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	3.76e-07	7.28e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	3.76e-07	7.28e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.75e-07	7.27e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.75e-07	7.26e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	3.75e-07	7.25e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.74e-07	7.24e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.74e-07	7.24e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.74e-07	7.24e-06	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.73e-07	7.23e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AGT—epilepsy syndrome	3.73e-07	7.22e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	3.71e-07	7.19e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	3.7e-07	7.17e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	3.7e-07	7.16e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	3.7e-07	7.16e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	3.69e-07	7.14e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.68e-07	7.12e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.67e-07	7.1e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.65e-07	7.08e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—epilepsy syndrome	3.65e-07	7.07e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.65e-07	7.07e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.62e-07	7.01e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	3.62e-07	7.01e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.61e-07	6.99e-06	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.61e-07	6.98e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	3.59e-07	6.96e-06	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.59e-07	6.95e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	3.57e-07	6.92e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	3.57e-07	6.92e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.57e-07	6.91e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	3.55e-07	6.88e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.53e-07	6.83e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TH—epilepsy syndrome	3.52e-07	6.81e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AGT—epilepsy syndrome	3.51e-07	6.8e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	3.5e-07	6.77e-06	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.49e-07	6.76e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.48e-07	6.74e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.48e-07	6.74e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—RELA—epilepsy syndrome	3.48e-07	6.73e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	3.47e-07	6.72e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	3.46e-07	6.69e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	3.45e-07	6.68e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—epilepsy syndrome	3.44e-07	6.66e-06	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.43e-07	6.65e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	3.42e-07	6.63e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RELA—epilepsy syndrome	3.41e-07	6.61e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.41e-07	6.6e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	3.41e-07	6.6e-06	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	3.41e-07	6.6e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.4e-07	6.59e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	3.4e-07	6.59e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.39e-07	6.57e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.39e-07	6.57e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.39e-07	6.57e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	3.38e-07	6.54e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.36e-07	6.51e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	3.36e-07	6.5e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	3.36e-07	6.5e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	3.36e-07	6.5e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.35e-07	6.49e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	3.35e-07	6.49e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.35e-07	6.48e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.34e-07	6.46e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.33e-07	6.44e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	3.3e-07	6.4e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.29e-07	6.38e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	3.29e-07	6.36e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.27e-07	6.34e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	3.27e-07	6.33e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.26e-07	6.31e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	3.22e-07	6.24e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	3.21e-07	6.23e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—POMC—epilepsy syndrome	3.21e-07	6.22e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.17e-07	6.14e-06	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.17e-07	6.13e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.14e-07	6.08e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	3.14e-07	6.07e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—POMC—epilepsy syndrome	3.14e-07	6.07e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	3.12e-07	6.04e-06	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.11e-07	6.03e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	3.11e-07	6.03e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	3.11e-07	6.03e-06	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.11e-07	6.02e-06	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.1e-07	6e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	3.1e-07	6e-06	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	3.09e-07	5.98e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	3.09e-07	5.98e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	3.08e-07	5.96e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	3.07e-07	5.94e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	3.06e-07	5.93e-06	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.06e-07	5.92e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.05e-07	5.91e-06	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.05e-07	5.91e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—JUN—epilepsy syndrome	3.05e-07	5.9e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.03e-07	5.87e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	3.03e-07	5.87e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	3.02e-07	5.85e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.02e-07	5.84e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	3.01e-07	5.83e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	3e-07	5.81e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.99e-07	5.79e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.98e-07	5.77e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.97e-07	5.76e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.97e-07	5.76e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	2.96e-07	5.74e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	2.96e-07	5.74e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.96e-07	5.72e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.94e-07	5.7e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.94e-07	5.68e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.93e-07	5.68e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.93e-07	5.68e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.93e-07	5.67e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.93e-07	5.67e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.92e-07	5.65e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.91e-07	5.64e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.91e-07	5.64e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.9e-07	5.62e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.89e-07	5.61e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.89e-07	5.6e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.89e-07	5.59e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	2.87e-07	5.57e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.86e-07	5.55e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—epilepsy syndrome	2.86e-07	5.54e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2.86e-07	5.53e-06	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.83e-07	5.49e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.83e-07	5.48e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.82e-07	5.47e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.82e-07	5.45e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.81e-07	5.45e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.81e-07	5.44e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.8e-07	5.43e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.78e-07	5.38e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.77e-07	5.36e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SRC—epilepsy syndrome	2.73e-07	5.29e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	2.73e-07	5.28e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.69e-07	5.22e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	2.69e-07	5.21e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.68e-07	5.2e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.67e-07	5.18e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.67e-07	5.17e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.67e-07	5.16e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	2.66e-07	5.15e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.65e-07	5.14e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.64e-07	5.11e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.63e-07	5.1e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.62e-07	5.07e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.62e-07	5.07e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.61e-07	5.06e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	2.61e-07	5.06e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.6e-07	5.04e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.6e-07	5.03e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.57e-07	4.98e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.57e-07	4.98e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.56e-07	4.97e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.56e-07	4.96e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.5e-07	4.85e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.5e-07	4.84e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	2.46e-07	4.77e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.45e-07	4.74e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	2.39e-07	4.62e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.38e-07	4.61e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	2.36e-07	4.57e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.36e-07	4.56e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.34e-07	4.53e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.3e-07	4.45e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.28e-07	4.42e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.25e-07	4.36e-06	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.24e-07	4.33e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	2.22e-07	4.3e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	2e-07	3.88e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2e-07	3.87e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.98e-07	3.84e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.93e-07	3.75e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.93e-07	3.74e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.92e-07	3.73e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.87e-07	3.62e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.84e-07	3.57e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.82e-07	3.52e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.76e-07	3.41e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.7e-07	3.29e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.67e-07	3.24e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.67e-07	3.23e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.66e-07	3.22e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.66e-07	3.21e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.64e-07	3.18e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.64e-07	3.17e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.54e-07	2.98e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.52e-07	2.94e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.29e-07	2.49e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.26e-07	2.43e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.18e-07	2.29e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.17e-07	2.27e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1e-07	1.94e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.75e-08	1.5e-06	CbGpPWpGaD
